![Izhak Haviv](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Izhak Haviv is the founder and current Chief Scientific Officer of AID Genomics Group Ltd., which is founded in 2018.
Actieve functies van Izhak Haviv
Bedrijven | Functie | Begin |
---|---|---|
AID Genomics Group Ltd.
![]() AID Genomics Group Ltd. Pharmaceuticals: MajorHealth Technology AID Genomics Group Ltd. is a research and development driven Israeli company that focuses on precision medicine-based diagnostics for oncology, hereditary rare diseases, and infectious diseases. AID Genomics Group is based in Rehovot, IL and was founded in 2018 by King Shiu Wu, Snir Zano, and Izhak Haviv. The company's advanced testing platforms were developed by a team of experts in oncology, molecular biology, molecular pathology, genomics, and bioinformatics. Snir Zano has been the CEO since 2018. | Oprichter | 01-01-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
AID Genomics Group Ltd.
![]() AID Genomics Group Ltd. Pharmaceuticals: MajorHealth Technology AID Genomics Group Ltd. is a research and development driven Israeli company that focuses on precision medicine-based diagnostics for oncology, hereditary rare diseases, and infectious diseases. AID Genomics Group is based in Rehovot, IL and was founded in 2018 by King Shiu Wu, Snir Zano, and Izhak Haviv. The company's advanced testing platforms were developed by a team of experts in oncology, molecular biology, molecular pathology, genomics, and bioinformatics. Snir Zano has been the CEO since 2018. | Health Technology |